Form D · Hedge Fund

QuantBio Innovations Fund LP

New York, NY · CIK 0001925468

Offering snapshot reported May 5, 2025 · SEC filing

Reported sold
$4.4M
Indefinite offering
Investors reported
15
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 9, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.2M$4.4MMay 5, 2022May 4, 2023: $3,836,000.00May 4, 2023May 3, 2024: $3,836,000.00May 3, 2024May 5, 2025: $4,401,000.00May 5, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,836,000 → $4,401,000
  • Reported investors12 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 5, 2025Amendment$4,401,000$565,000vs May 3, 202415SEC filing
May 3, 2024Amendment$3,836,000$0vs May 4, 202312SEC filing
May 4, 2023Amendment$3,836,000No comparison12SEC filing
May 5, 2022InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-444527

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
GALLATIN CAPITAL LLC124738

Source: Form D, filed May 5, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

QUANTBIO INNOVATIONS FUND LP

Investment adviser: OBERLAND CAPITAL MANAGEMENT LLC

Gross asset value
$11.1M
Beneficial owners
24
ADV minimum commitment
$150K

Reported in Form ADV on May 1, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator SEI OAKS, Pennsylvania, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor PRICEWATERHOUSECOOPERS NEW YORK, New York, United States
Custodian INTERACTIVE BROKERS LLC GREENWICH, Connecticut, United States Related to adviser: No
Marketer GALLATIN CAPITAL LLC NEW YORK, New York, United States Related to adviser: No
Prime broker INTERACTIVE BROKERS LLC GREENWICH, Connecticut, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

PRICEWATERHOUSECOOPERS
PCAOB 238

INTERACTIVE BROKERS LLC
SEC 8-47257

GALLATIN CAPITAL LLC
CRD 124738 · SEC 8-65718

INTERACTIVE BROKERS LLC
CRD 36418 · SEC 8-47257

Filing source

Form ADV 2102480 · May 1, 2026 · Schedule D 7.B.(1), fund 805-1717867025

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jean Pierre Naegeli Executive
Andrew Rubinstein Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Quantbio Management Llc 1700 Broadway, 24 Th Floor
New York, NY, 10019